Navigation Links
Simple, Sensitive Isotyping of Mouse Monoclonal Antibodies

Monoclonal antibody isotyping in only 5 minutes

Weiping Yang Matt C. Petre Darrel Holmes Peter L. Pingerelli
Stratagene Cloning Systems, Inc.

Stratagenes IsoDetect mouse monoclonal antibody isotyping kit is a simple, rapid and sensitive method for identifying mouse monoclonal antibody isotypes in a single step. Each IsoDetect test card is a self-contained assay, using colloidal gold-conjugated anti-mouse antibodies for isotype determination of 0.1 g/ml of antibody in 5 minutes.

For decades, antibodies have been used as key reagents for biological research. The development of hybridoma technology, which generates monoclonal antibodies, has resulted in the development of a significant number of immunoglobulins for research and diagnostics. As knowledge concerning the production of monoclonal antibodies has grown, these powerful tools have become more commonplace, and thousands of new monoclonal antibodies are made each year.

Mouse immunoglobulins have been classified into five primary classes (IgG, IgM, IgA, IgD and IgE) according to differences in their heavy chain polypeptides (the immunoglobulin classes have g, , a, d and e heavy chains, respectively). The antigenic differences among the five classes are located primarily on the Fc fragments of the heavy chains. These differences allow immunoglobulins to function at particular stages in a variety of immune responses. IgG molecules are further subclassed based on the antigenicity of the four isotypes. Mouse IgG isotypes are designated IgG1, IgG2a, IgG2b and IgG3.

Because the biological functions and biochemical characteristics of classes and isotypes differ, distinguishing the classes and isotypes of an immunoglobulin molecule is critical. Knowl
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
4. The DIG System Nonradioactive and Highly Sensitive Detection of Nucleic Acids
5. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
6. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
7. Highly Sensitive microRNA Array Performance
8. Sensitive identification of phosphopeptides in brain tissue using Ettan MDLC and Finnigan LTQ
9. Simultaneous Detection of CYP3A4, CYP2D6 and CYP2C9 Metabolites with a Single, Sensitive, LC/MS/MS Method
10. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
11. Mouse Tail Genomic DNA Isolation Protocol(1)

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Simple Sensitive Isotyping Mouse Monoclonal Antibodies

(Date:11/5/2009)...URG, Md., Nov. 5 GenVec,...al results for the third quarter ended September 3...n ($0.04 per share) for the three months ended Sep...lion ($0.08 per share) in the comparable quarter o...09, GenVec,s net loss was $14.1 million ($0.15 per...
(Date:11/5/2009)...RDOVA, Calif., Nov. 5 Th...lier of innovative products for processing and sto...the first quarter of fiscal 2010. ,, For the qu...ed revenues of $5.2 million, a 15 percent increase...r a year ago. The Company said the key contributor...
(Date:11/5/2009)..., Calif., Nov. 5 Cepheid...ves will be speaking at the following investor con... webcast. , , Credit Suisse Health...sday, 12 November, 2009 at 10 a.m. Mountain Time,... London, England, Tuesday, 1 Decem...
(Date:11/5/2009)...exas, Nov. 5 SpineSmith Partners h... to co-develop a unique scaffold that mimics the s...aluation of several commercial products by SpineSm...pany believes the GenOsteo scaffold represents a s...a unique and ideal environment for the delivery of...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...SAN DIEGO, March 2 BioMed Realty Trust, Inc. (NYS...cutive management will present at the Citi 2009 Gl... approximately 9:05 a.m. Eastern Standard Time on ...ll be open to all investors by calling 719.785.559...ioMed Realty Trust , BioMed Realty Trust, Inc. is...
..., Innovative B.C. Technology Promises to Revolu...ER, March 2 /PRNewswire-FirstCall/ - EnWave Corpor...ay announced that it has completed the first sale ...uipment to CAL-SAN Enterprises, Ltd. of Richmond, ...producers. With this sale, EnWave has proven that ...
... EXTON, Pa., March 2 Morphotek(R), Inc., a sub...ay announced that it has commenced a,multi-centere...ody in,mesothelioma. The study will evaluate MORAb...isplatinum, as a first-line treatment for patients... the study is to assess the efficacy of MORAb-009,...
Other Biology Technology:EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 2EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 3EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 4Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Hormone therapy may confer more aggressive properties to prostate tumors 48453 1Drugs against winter vomiting disease one step closer 48451 1Drugs against winter vomiting disease one step closer 48451 2New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 1New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 2
...immune system cells go through a laboratory versio...against HIV, believe University of Pittsburgh rese... development of a novel therapeutic vaccine loaded...hich have been galvanized to rally other cells of ...that individual. , At the XVI International AIDS ...
... the Harvard Department of Ophthalmology,s Schepen... Ear Infirmary (MEEI) are the first to learn why t... blood vessels--a unique phenomenon that makes vis... unexpected presence of large amounts of the prote...eptor-3) on the top epithelial layer of normal hea...
...e has its place and role in the oceans ?even the s... lead to more accurate models of ocean change. , ...que biological niche for most animals and plants ?...dolphin. , Bacteria instead have been relegated ... which few species are considered unique, said Jed...
Other Biology News:T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 2T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 3Scientists discover why cornea is transparent and free of blood vessels, allowing vision 2Scientists discover why cornea is transparent and free of blood vessels, allowing vision 3Bacteria can help predict ocean change 2
Mouse Anti-Human E1A (adenovirus early region 1) Monoclonal Antibody, Unconjugated, Clone M73 from Exalpha Biologicals, Inc.
Blocking Reagent, TBS with 1% BSA from Bethyl Laboratories
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
RayBio Human Chemokine Antibody Array I & 1.1 Service from Raybiotech, Inc.
Biology Products: